e.g. Tata motors, Reliance MF, 500570

Aurobindo Pharma Ltd. - Research Center

524804 AUROPHARMA Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 26 Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 11,171.72 10,933.30 10,645.64 12,792.28 11,287.14
Expenses
Material consumed 5,428.04 5,680.64 5,917.42 7,009.99 5,981.37
Manufacturing expenses 174.82 185.59 191.58 613.92 477.99
Personnel expenses 1,161.15 1,063.07 980.56 1,641.88 1,600.04
Selling expenses - - - - -
Adminstrative expenses 1,315.77 1,446.43 1,332.04 1,795.57 1,754.34
Expenses capitalised - - - - -
Cost of sales 8,079.78 8,375.73 8,421.60 11,061.36 9,813.74
Operating profit 3,091.94 2,557.57 2,224.04 1,730.92 1,473.40
Other recurring income 587.53 328.12 616.06 433.76 670.99
Adjusted PBDIT 3,679.47 2,885.69 2,840.10 2,164.68 2,144.39
Financial expenses 213.15 230.04 182.60 114.98 16.94
Depreciation 285.36 297.20 254.58 435.35 415.26
Other write offs - - - - -
Adjusted PBT 3,180.96 2,358.45 2,402.92 1,614.35 1,712.19
Tax charges 748.78 611.66 502.82 383.94 182.77
Adjusted PAT 2,432.18 1,746.79 1,900.10 1,230.41 1,529.42
Non recurring items -16.30 -5.26 52.35 5.87 -73.02
Other non cash adjustments - - - - -
Reported net profit 2,415.88 1,741.53 1,952.45 1,236.28 1,456.40
Earnigs before appropriation 22,506.28 20,090.40 18,612.53 17,100.42 16,127.81
Equity dividend 232.30 - 263.66 439.45 263.67
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 22,273.98 20,090.40 18,348.87 16,660.97 15,864.14
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback